To: "NOVA CFS/ME, FMS, OI & Gratitude Support Groups" <email@example.com>
The Advisory committee will discuss new drug application (NDA) 22151, rintatolimod injection (proposed trade name AMPLIGEN) submitted by Hemispherx Biopharma, Inc. for the treatment of patients with chronic fatigue syndrome.
Info FDA Website: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm
Subject line: Ampligen-Treatment for Chronic Fatigue Syndrome CFS/ME
To The Advisory Committee Reviewing Ampligen:
My name is _____________, I have had CFS for more than ___ years. Before I became ill I had a life that was____ your story here__. My life since having CFS has been __your story here_. After 3 decades, We Need treatment. We deserve treatment and the ability to access it. Just like AZT for AIDS, Chemo for Cancer, Tysarbri for MS or Benlysta for Lupus. We are not second class patients. Reality of CFS, it is Serious and Life Threatening. According to CDC studies, CFS is comparable to MS, AIDS, Lupus, Rheumatoid Arthritis, Heart Disease, Renal Failure, COPD and Chemotherapy. CFS/ME effects every moment of my life. We've seen and heard of patients responding to Ampligen. Give patients Hope by approving Ampligen. We want our lives back.
- What: Ampligen is being presented in front of the Arthritis Advisory Committee which is a result of consolidating the review of all drugs for ME/CFS under one division, the division of Division of Pulmonary, Allergy and Rheumatology Products. Additional information can be found here: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm
- When: Dec 20, 2012 from 8:00 am to 5:00 pm
- Where: FDA White Oak Campus, Building 31, Great Room (Rm. 1503), White Oak Conference Center, 10903 New Hampshire Avenue Silver, Spring, Maryland
- Getting there: The Metro 'Red Line' goes to Silver Springs. From there, you need to take a bus or a 20 minute taxi to the FDA campus. There is also a bus that operates in the morning til about 9:00 but you will need to walk up a hill to get to it. Further details can be found here